PortfoliosLab logoPortfoliosLab logo
CRBU vs. SDGR
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CRBU vs. SDGR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Caribou Biosciences, Inc. (CRBU) and Schrodinger, Inc. (SDGR). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CRBU achieves a -8.18% return, which is significantly higher than SDGR's -15.32% return.


CRBU

1D
-3.31%
1M
-19.78%
6M
3.55%
YTD
-8.18%
1Y
-25.13%
3Y*
-41.55%
5Y*
-38.20%
10Y*
ALL TIME*
-39.13%

SDGR

1D
-1.37%
1M
-10.31%
6M
8.38%
YTD
-15.32%
1Y
-22.48%
3Y*
-33.86%
5Y*
-25.88%
10Y*
ALL TIME*
-8.01%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$1.81M$3.07M$3.70M
$12.37M$14.56M$19.33M

CRBU vs. SDGR - Yearly Performance Comparison


2026 (YTD)20252024202320222021
CRBU
Caribou Biosciences, Inc.
-8.18%0.00%-72.25%-8.76%-58.38%-14.50%
SDGR
Schrodinger, Inc.
-15.32%-7.31%-46.12%91.55%-46.34%-50.30%

Correlation

The correlation between CRBU and SDGR is 0.37, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.37

Correlation (3Y)
Balances recent behavior with more history.

0.44

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.48

Correlation (All Time)
Calculated using the full available price history since Jul 23, 2021

0.47

The correlation between CRBU and SDGR shifts across timeframes, from 0.37 (1 year) to 0.48 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

CRBU:

$144.80M

SDGR:

$1.13B

EPS

CRBU:

-$1.41

SDGR:

-$1.40

PS Ratio

CRBU:

15.68

SDGR:

4.38

PB Ratio

CRBU:

1.37

SDGR:

3.57

Total Revenue (TTM)

CRBU:

$8.81M

SDGR:

$254.91M

Gross Profit (TTM)

CRBU:

$7.49M

SDGR:

$141.04M

EBITDA (TTM)

CRBU:

-$115.23M

SDGR:

-$85.22M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CRBU vs. SDGR — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

CRBU
CRBU Risk / Return Rank: 2828
Overall Rank
CRBU Sharpe Ratio Rank: 2727
Sharpe Ratio Rank
CRBU Sortino Ratio Rank: 3030
Sortino Ratio Rank
CRBU Omega Ratio Rank: 3131
Omega Ratio Rank
CRBU Calmar Ratio Rank: 2424
Calmar Ratio Rank
CRBU Martin Ratio Rank: 2626
Martin Ratio Rank

SDGR
SDGR Risk / Return Rank: 2424
Overall Rank
SDGR Sharpe Ratio Rank: 2222
Sharpe Ratio Rank
SDGR Sortino Ratio Rank: 2323
Sortino Ratio Rank
SDGR Omega Ratio Rank: 2424
Omega Ratio Rank
SDGR Calmar Ratio Rank: 2626
Calmar Ratio Rank
SDGR Martin Ratio Rank: 2828
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

CRBU vs. SDGR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Caribou Biosciences, Inc. (CRBU) and Schrodinger, Inc. (SDGR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CRBUSDGRDifference
Sharpe ratioReturn per unit of total volatility

+0.12

Sortino ratioReturn per unit of downside risk

+0.33

Omega ratioGain probability vs. loss probability

0.99

0.95

+0.04

Calmar ratioReturn relative to maximum drawdown

-0.55

-0.50

-0.05

Martin ratioReturn relative to average drawdown

-0.89

-0.82

-0.07

CRBU vs. SDGR - Sharpe Ratio Comparison

The current CRBU Sharpe Ratio is -0.38, which is comparable to the SDGR Sharpe Ratio of -0.50. The chart below compares the historical Sharpe Ratios of CRBU and SDGR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CRBU vs. SDGR - Drawdown Comparison

The maximum CRBU drawdown since its inception was -97.58%, which is greater than SDGR's maximum drawdown of -90.21%. Use the drawdown chart below to compare losses from any high point for CRBU and SDGR.


Loading charts...

Drawdown Indicators


CRBUSDGRDifference

Max Drawdown

Largest peak-to-trough decline

-97.58%

-90.21%

-7.37%

Max Drawdown (1Y)

Largest decline over 1 year

-51.06%

-50.84%

-0.22%

Max Drawdown (3Y)

Largest decline over 3 years

-91.12%

-72.25%

-18.87%

Max Drawdown (5Y)

Largest decline over 5 years

-97.58%

-83.96%

-13.62%

Current Drawdown

Current decline from peak

-95.18%

-86.61%

-8.57%

Average Drawdown

Average peak-to-trough decline

-79.71%

-64.53%

-15.18%

Ulcer Index

Depth and duration of drawdowns from previous peaks

31.64%

31.07%

+0.57%

Volatility

CRBU vs. SDGR - Volatility Comparison

Caribou Biosciences, Inc. (CRBU) has a higher volatility of 13.75% compared to Schrodinger, Inc. (SDGR) at 9.40%. This indicates that CRBU's price experiences larger fluctuations and is considered to be riskier than SDGR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CRBUSDGRDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.75%

9.40%

+4.35%

Volatility (6M)

Calculated over the trailing 6-month period

48.91%

37.40%

+11.51%

Volatility (1Y)

Calculated over the trailing 1-year period

74.25%

51.61%

+22.64%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

86.14%

63.43%

+22.71%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

86.04%

69.50%

+16.54%

Dividends

CRBU vs. SDGR - Dividend Comparison

Neither CRBU nor SDGR has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

CRBU vs. SDGR - Financials Comparison

This section allows you to compare key financial metrics between Caribou Biosciences, Inc. and Schrodinger, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


CRBU and SDGR have a correlation of 0.37, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CRBU has higher volatility (13.75%) compared to SDGR (9.40%). In terms of maximum drawdown, CRBU dropped -97.58% vs SDGR's -90.21%.

CRBU currently has the higher Sharpe Ratio (-0.38 vs -0.50), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CRBU and SDGR

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer